Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 43, 2021 - Issue 3
194
Views
14
CrossRef citations to date
0
Altmetric
Original Research Paper

Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma

, &
Pages 210-219 | Received 16 Apr 2020, Accepted 09 Oct 2020, Published online: 18 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Dapeng Wu, Sai Tian & Wenjing Zhu. (2023) Modulating multidrug resistance to drug-based antitumor therapies through NF-κB signaling pathway: mechanisms and perspectives. Expert Opinion on Therapeutic Targets 27:6, pages 503-515.
Read now
Jian-Qing Chen, Yuan-Ping Tao, Yong-Gang Hong, Hui-Fen Li, Zhi-Ping Huang, Xuan-Fu Xu & Liang-Kai Hu. (2021) M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling. Cell Cycle 20:23, pages 2507-2518.
Read now

Articles from other publishers (11)

Aryan Rezaee, Pooya M. Tehrany, Farimah Jafari Tirabadi, Negin Sanadgol, Asal Sadat Karimi, Atra Ajdari, Sepideh Eydivandi, Sara Etemad, Romina Rajabi, Parham Rahmanian, Ramin Khorrami, Noushin Nabavi, Amir Reza Aref, Xiaoping Fan, Rongjun Zou, Mohsen Rashidi, Mohammad Arad Zandieh & Kiavash Hushmandi. (2023) Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs. Biomedicine & Pharmacotherapy 165, pages 115187.
Crossref
Peng Song, Ying Li, Feng Wang, Lingxiao Pu, Linsen Bao, Hengfei Gao, Chuandong Zhu, Meng Wang & Liang Tao. (2022) Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer. Clinical Epigenetics 14:1.
Crossref
Sui Li, Xiaofang Xie, Fu Peng, Junrong Du & Cheng Peng. (2022) Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review). International Journal of Oncology 61:3.
Crossref
Wenxing He, Dongmei Li & Xiaofang Zhang. (2022) LncRNA HOTAIR promotes the proliferation and invasion/metastasis of breast cancer cells by targeting the miR-130a-3p/Suv39H1 axis. Biochemistry and Biophysics Reports 30, pages 101279.
Crossref
Sushanta Halder, Seema Parte, Prakash Kshirsagar, Sakthivel Muniyan, Hareesh B. Nair, Surinder K. Batra & Parthasarathy Seshacharyulu. (2022) The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:4, pages 188737.
Crossref
Seyed Mojtaba Mousavi, Maryam Derakhshan, Fatereh Baharloii, Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Maryam Mahjoubin-Tehran, Saereh Hosseindoost, Pouya Goleij, Neda Rahimian, Michael R. Hamblin & Hamed Mirzaei. (2022) Non-coding RNAs and glioblastoma: Insight into their roles in metastasis. Molecular Therapy - Oncolytics 24, pages 262-287.
Crossref
Megan M. Jorgensen & Pilar de la Puente. (2022) Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer. Biomolecules 12:2, pages 217.
Crossref
Zhiqun Bai, Xuemei Wang & Zhen Zhang. (2022) Long Noncoding RNA LIFR-AS1: A New Player in Human Cancers. BioMed Research International 2022, pages 1-11.
Crossref
Meisam Akhlaghdoust, Soheil Tavakolpour, Poorya Davoodi, Shayan Rahmani, Alireza Zali & Nima Rezaei. 2022.
Soudeh Ghafouri-Fard, Afete Abak, Faranak Fattahi, Bashdar M. Hussen, Zahra Bahroudi, Hamed Shoorei & Mohammad Taheri. (2021) The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders. Biomedicine & Pharmacotherapy 138, pages 111519.
Crossref
Sha Li, Chen Wang, Yifang Lu & Weijuan Li. (2021) Long non-coding RNA LIFR-AS1 regulates the proliferation, migration and invasion of human thyroid cancer cells. 3 Biotech 11:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.